Triptolide Ameliorates Crohn'S Colitis Is Associated With Inhibition Of Tlrs/Nf-Kappa B Signaling Pathway

Chao Yu,Ting Shan,Aiwen Feng,Yi Li,Weiming Zhu,Ying Xie,Ning Li,Jieshou Li

DOI: https://doi.org/10.1016/j.fitote.2011.02.011

IF: 3.204

2011-01-01

Fitoterapia

Abstract:Growing evidence suggests that TLRs/NF-kappa B signaling pathway plays a critical role in the pathogenesis of Crohn's disease (CD). We have reported that triptolide, an active component from Tripterygium wilfordii Hook, showed therapeutic activity in IL-10-deficeint (1L-10(-)/(-)) mice, a murine CD model. However the full mechanisms of action of this agent in CD remain largely unknown. We hypothesized that triptolide would ameliorate the experimental colitis by inhibiting TLRs/NF-kappa B signaling pathway. We found TLR2 and TLR4 were upregulated in IL10(-)/(-) mice, triptolide inhibited the TLRs/NF-kappa B signaling pathway in vivo. In addition, triptolide in vitro was able to downregulate the TLRs/NF-kappa B pathway in cultured colonic explants from CD patients. Our results confirm the therapeutic effect of triptolide in experimental colitis, and suggest it as a promising compound for CD treatment. These findings also support the possibility that targeted inhibition of TLR signaling pathway is an approach deserving further investigation as a therapeutic strategy for CD. (C) 2011 Elsevier B.V. All rights reserved.